Maria E. Fermento
Bahia Blanca, B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Heme-oxygenase-1: a key player in thyroid carcinoma development.
Journal: Endocrine-related cancer
Published: February 17, 2025
GEF-H1 drives breast cancer cells to tumor progression.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: December 20, 2024
Amorphous silica nanoparticles exhibit antitumor activity in triple-negative breast cancer cells.
Journal: Archiv der Pharmazie
Published: April 26, 2024
New insights on neurodegeneration triggered by iron accumulation: Intersections with neutral lipid metabolism, ferroptosis, and motor impairment.
Journal: Redox biology
Published: October 30, 2023
Hemoxygenase-1 Promotes Head and Neck Cancer Cell Viability.
Journal: Antioxidants (Basel, Switzerland)
Published: September 05, 2022
Heme Oxygenase-1 Has an Antitumor Role in Breast Cancer.
Journal: Antioxidants & redox signaling
Published: November 29, 2018
Antitumoral effects of the alkynylphosphonate analogue of calcitriol EM1 on glioblastoma multiforme cells.
Journal: The Journal of steroid biochemistry and molecular biology
Published: August 09, 2017
Antitumoral Effects of D-Fraction from Grifola Frondosa (Maitake) Mushroom in Breast Cancer.
Journal: Nutrition and cancer
Published: November 29, 2016
The UVB1 Vitamin D analogue inhibits colorectal carcinoma progression.
Journal: The Journal of steroid biochemistry and molecular biology
Published: March 03, 2016
The alkynylphosphonate analogue of calcitriol EM1 has potent anti-metastatic effects in breast cancer.
Journal: The Journal of steroid biochemistry and molecular biology
Published: June 21, 2015
Vitamin D analogue: potent antiproliferative effects on cancer cell lines and lack of hypercalcemic activity.
Journal: Archiv der Pharmazie
Published: December 04, 2014
Last Updated: 09/26/2026